EN
HI
Emcure Pharmaceuticals share price chart
Emcure Pharmaceuticals Share Key Metrics
Volume
1.02 L
Market Cap
35456.85 CR
LTQ@LTP
3@1869.50
ATP
1887.6
Var Margin
16.97 %
Circuit Range
1700.3-2078.1
Delivery %
48.63 %
Value
19.28 CR
ASM/GSM
No
Market Lot
1
Summary
EMCURE stock price is ₹1869.5 as of 23 Jul, 2026. The stock intraday movement has stayed between ₹1864.20 and ₹1928.10, while Emcure Pharmaceuticals share price 52 week high low is ₹1260.00 & ₹1944.00.
In terms of trading activity, EMCURE share price has recorded a volume of 1,02,140 shares. The Emcure Pharmaceuticals has a market cap of ₹189659547. The stock’s Average Traded Price (ATP) stands at ₹1887.60, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹1869.50.
The Emcure Pharmaceuticals upper circuit limit is ₹2078.10 & The Emcure Pharmaceuticals lower circuit limit is ₹1700.30, with a Value of ₹19.28 CR. The Delivery Percentage for the day is 48.63%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Emcure Pharmaceuticals Fundamentals
P/E Ratio
38.8
P/B Ratio
7.25
Div. Yield
0.19
Sector P/E
66.45
Sector P/B
3.25
Sec. Div. Yield
0.53
Emcure Pharmaceuticals Resistance and Support
Pivot 1900.77
Resistance
First Resistance
1924.54
Second Resistance
1959.87
Third Resistance
1983.64
Support
First Support
1865.44
Second Support
1841.67
Third Support
1806.34
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals News
Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On Completion Of Acquisition Of Shares Of Gennova Biopharmaceuticals Limited.
Emcure Pharma completed the acquisition of the remaining 12.05% stake in Gennova Biopharmaceuticals for Rs. 231.87 crore. This makes Gennova a wholly-owned subsidiary, consolidating its biotechnology-based products business.
Jul 22 2026 18:08:07
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Emcure Pharmaceuticals received CDSCO approval for Poviztra® to treat non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis. This approval expands the use of the innovator semaglutide, addressing an unmet medical need in India.
Jul 20 2026 16:18:56
Read More
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Glaxosmithkline Pharmaceuticals Ltd.
2495.00
-57.80 (2.26%)
Gland Pharma Ltd.
2377.70
-61.40 (2.52%)
Narayana Hrudayalaya Ltd.
1982.50
14.50 (0.74%)
Global Health Ltd.
1378.20
24.80 (1.83%)
Krishna Institute of Medical Sciences Ltd
781.55
-2.90 (0.37%)
Wockhardt Ltd.
1849.70
-11.80 (0.63%)
Acutaas Chemicals Ltd.
3459.10
-200.50 (5.48%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 1869.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 38.8. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 7.25. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 66.45 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 35456.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 1944.00 & 1260.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
